Thousands of bottles of a commonly used prescription drug to treat hypertension have been recalled for possible contamination with another drug, reports USA Today.
Glenmark Pharmaceuticals, which has its US headquarters in New Jersey, has recalled multiple lots of bisoprolol fumarate and hydrochlorothiazide tablets (brand name Ziac), because the tablets may have been cross-contaminated with other products, according to a recall report published online by the Food and Drug Administration.
The global drug maker, which is headquartered in Mumbai, India, said testing of reserve samples showed presence of traces of ezetimibe, a cholesterol drug the company also produces, according to the recall, posted last week.
The FDA classified the recall with a Class III risk level, which suggests “use of or exposure to a violative product is not likely to cause adverse health consequences”, according to the agency.
The recall involves an undeclared number of lots of tablets, from 2.5 mg to 6.25 mg dosages, in various sized bottles, manufactured in Madhya Pradesh, India for Glenmark, USA.
USA Today article – Blood pressure drug recalled for possible cross-contamination (Open access)
See more from MedicalBrief archives:
Indian firm recalls two dozen medications sold to US patients
FDA failures in policing Indian manufacturers of generics
New drug-making standards set for Indian firms